Vanguard Group’s VIVEVE MED INC VIVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-60,344
| Closed | -$25.6K | – | 4650 |
|
|
2022
Q4 | $25.6K | Sell |
60,344
-53,667
| -47% | -$27K | ﹤0.01% | 4485 |
|
|
2022
Q3 | $78K | Hold |
114,011
| – | – | ﹤0.01% | 4514 |
|
|
2022
Q2 | $75K | Hold |
114,011
| – | – | ﹤0.01% | 4564 |
|
|
2022
Q1 | $121K | Sell |
114,011
-27,095
| -19% | -$27.1K | ﹤0.01% | 4584 |
|
|
2021
Q4 | $161K | Buy |
141,106
+26,867
| +24% | +$49.3K | ﹤0.01% | 4580 |
|
|
2021
Q3 | $260K | Hold |
114,239
| – | – | ﹤0.01% | 4467 |
|
|
2021
Q2 | $338K | Buy |
114,239
+28,660
| +33% | +$80.6K | ﹤0.01% | 4320 |
|
|
2021
Q1 | $262K | Buy |
85,579
+70,000
| +449% | +$257K | ﹤0.01% | 4228 |
|
|
2020
Q4 | $73K | Buy |
+15,579
| New | +$78.4K | ﹤0.01% | 4167 |
|
|
2019
Q3 | – | Sell |
-1,369
| Closed | -$520K | – | 4170 |
|
|
2019
Q2 | $520K | Sell |
1,369
-461
| -25% | -$250K | ﹤0.01% | 3820 |
|
|
2019
Q1 | $1.72M | Buy |
1,830
+147
| +9% | +$156K | ﹤0.01% | 3500 |
|
|
2018
Q4 | $1.77M | Buy |
1,683
+702
| +72% | +$1.69M | ﹤0.01% | 3414 |
|
|
2018
Q3 | $2.63M | Buy |
981
+7
| +0.7% | +$19.8K | ﹤0.01% | 3441 |
|
|
2018
Q2 | $2.65M | Sell |
974
-19
| -2% | -$54.7K | ﹤0.01% | 3414 |
|
|
2018
Q1 | $3.63M | Buy |
993
+468
| +89% | +$2.04M | ﹤0.01% | 3266 |
|
|
2017
Q4 | $2.61M | Buy |
525
+62
| +13% | +$323K | ﹤0.01% | 3344 |
|
|
2017
Q3 | $2.42M | Buy |
463
+13
| +3% | +$80.1K | ﹤0.01% | 3347 |
|
|
2017
Q2 | $3.23M | Buy |
450
+259
| +136% | +$1.93M | ﹤0.01% | 3240 |
|
|
2017
Q1 | $1.21M | Buy |
191
+172
| +905% | +$837K | ﹤0.01% | 3530 |
|
|
2016
Q4 | $96K | Buy |
+19
| New | +$113K | ﹤0.01% | 3974 |
|
Other funds holding VIVE
Vanguard Group's VIVE Position: Q1 2023 in Review
Vanguard Group sold out of VIVEVE MED INC (VIVE) in Q1 2023, closing a stake of 60,344 shares — an estimated $25.6K sold.
Vanguard Group first reported a position in VIVE in Q4 2016 and held it in 20 quarters. The position peaked at $3.63M in Q1 2018. 1 fund tracked by Wall St. Rank holds VIVE as of Q1 2023.
- Vanguard Group reported no remaining VIVEVE MED INC position as of Q1 2023 after selling out during the quarter.
- Vanguard Group sold 60,344 VIVEVE MED INC shares in Q1 2023, an estimated $25.6K.
- Vanguard Group first reported a position in VIVEVE MED INC in Q4 2016 and held it in 20 quarters.
- Vanguard Group's VIVEVE MED INC position peaked at $3.63M in Q1 2018.
- 1 fund tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2023.
Based on Vanguard Group's 13F filing for Q1 2023, filed 15 May 2023.